Cargando…
Brain-derived neurotrophic factor (BDNF) polymorphism may influence the efficacy of tACS to modulate neural oscillations
Autores principales: | Riddle, Justin, McPherson, Trevor, Atkins, Alana K., Walker, Christopher P., Ahn, Sangtae, Frohlich, Flavio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191595/ https://www.ncbi.nlm.nih.gov/pubmed/32330606 http://dx.doi.org/10.1016/j.brs.2020.04.012 |
Ejemplares similares
-
A case study of weekly tACS for the treatment of major depressive disorder
por: Riddle, Justin, et al.
Publicado: (2019) -
Conducting double-blind placebo-controlled clinical trials of transcranial alternating current stimulation (tACS)
por: Frohlich, Flavio, et al.
Publicado: (2021) -
A case study of the feasibility of weekly tACS for the treatment of auditory hallucinations in schizophrenia
por: Force, Rachel B., et al.
Publicado: (2021) -
Double-blind, randomized pilot clinical trial targeting alpha oscillations with transcranial alternating current stimulation (tACS) for the treatment of major depressive disorder (MDD)
por: Alexander, Morgan L., et al.
Publicado: (2019) -
tACS Phase Locking of Frontal Midline Theta Oscillations Disrupts Working Memory Performance
por: Chander, Bankim S., et al.
Publicado: (2016)